MidWestOne Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.62M | Sell |
15,094
-506
| -3% | -$54.3K | 0.21% | 111 |
|
2025
Q1 | $1.57M | Buy |
15,600
+677
| +5% | +$68.3K | 0.22% | 103 |
|
2024
Q4 | $1.33M | Sell |
14,923
-789
| -5% | -$70.5K | 0.19% | 114 |
|
2024
Q3 | $1.32M | Sell |
15,712
-934
| -6% | -$78.3K | 0.18% | 119 |
|
2024
Q2 | $1.28M | Sell |
16,646
-619
| -4% | -$47.7K | 0.23% | 114 |
|
2024
Q1 | $1.18M | Buy |
17,265
+168
| +1% | +$11.5K | 0.21% | 127 |
|
2023
Q4 | $988K | Buy |
17,097
+90
| +0.5% | +$5.2K | 0.19% | 135 |
|
2023
Q3 | $898K | Buy |
17,007
+1,882
| +12% | +$99.4K | 0.2% | 128 |
|
2023
Q2 | $818K | Buy |
15,125
+2,249
| +17% | +$122K | 0.18% | 146 |
|
2023
Q1 | $644K | Buy |
12,876
+797
| +7% | +$39.9K | 0.15% | 165 |
|
2022
Q4 | $559K | Buy |
12,079
+4,813
| +66% | +$223K | 0.12% | 171 |
|
2022
Q3 | $281K | Sell |
7,266
-183
| -2% | -$7.08K | 0.07% | 197 |
|
2022
Q2 | $278K | Sell |
7,449
-621
| -8% | -$23.2K | 0.07% | 196 |
|
2022
Q1 | $357K | Sell |
8,070
-372
| -4% | -$16.5K | 0.08% | 197 |
|
2021
Q4 | $359K | Buy |
8,442
+127
| +2% | +$5.4K | 0.08% | 195 |
|
2021
Q3 | $361K | Sell |
8,315
-387
| -4% | -$16.8K | 0.08% | 182 |
|
2021
Q2 | $372K | Sell |
8,702
-12,104
| -58% | -$517K | 0.09% | 176 |
|
2021
Q1 | $804K | Sell |
20,806
-4,213
| -17% | -$163K | 0.19% | 116 |
|
2020
Q4 | $899K | Buy |
25,019
+9,446
| +61% | +$339K | 0.25% | 102 |
|
2020
Q3 | $595K | Sell |
15,573
-2,638
| -14% | -$101K | 0.2% | 128 |
|
2020
Q2 | $639K | Buy |
18,211
+8,955
| +97% | +$314K | 0.27% | 73 |
|
2020
Q1 | $302K | Buy |
9,256
+333
| +4% | +$10.9K | 0.11% | 151 |
|
2019
Q4 | $403K | Sell |
8,923
-291
| -3% | -$13.1K | 0.08% | 171 |
|
2019
Q3 | $375K | Sell |
9,214
-1,105
| -11% | -$45K | 0.12% | 162 |
|
2019
Q2 | $444K | Buy |
+10,319
| New | +$444K | 0.12% | 175 |
|